116 related articles for article (PubMed ID: 37417972)
1. Enhanced Cytotoxic Activity of 6-Mercaptopurine-Loaded Solid Lipid Nanoparticles in Hepatic Cancer Treatment.
Ergin AD; Oltulu Ç; Koç B
Assay Drug Dev Technol; 2023 Jul; 21(5):212-221. PubMed ID: 37417972
[TBL] [Abstract][Full Text] [Related]
2. The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method.
Nabi-Meibodi M; Vatanara A; Najafabadi AR; Rouini MR; Ramezani V; Gilani K; Etemadzadeh SM; Azadmanesh K
Colloids Surf B Biointerfaces; 2013 Dec; 112():408-14. PubMed ID: 24036624
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles as tool for enhanced ophthalmic delivery of vancomycin: a multidistrict-based microbiological study, solid lipid nanoparticles formulation and evaluation.
Yousry C; Fahmy RH; Essam T; El-Laithy HM; Elkheshen SA
Drug Dev Ind Pharm; 2016 Nov; 42(11):1752-62. PubMed ID: 27093938
[TBL] [Abstract][Full Text] [Related]
4. Quality by Design Approach for Development and Characterisation of Solid Lipid Nanoparticles of Quetiapine Fumarate.
Agarwal S; Murthy RSR; Harikumar SL; Garg R
Curr Comput Aided Drug Des; 2020; 16(1):73-91. PubMed ID: 31429691
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid-based nanoparticulate system for sustained release and enhanced in-vitro cytotoxic effect of 5-fluorouracil on skin Melanoma and squamous cell carcinoma.
Ali A; Madni A; Shah H; Jamshaid T; Jan N; Khan S; Khan MM; Mahmood MA
PLoS One; 2023; 18(2):e0281004. PubMed ID: 36854019
[TBL] [Abstract][Full Text] [Related]
6. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
[TBL] [Abstract][Full Text] [Related]
7. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
8. Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer.
Yassin AE; Anwer MK; Mowafy HA; El-Bagory IM; Bayomi MA; Alsarra IA
Int J Med Sci; 2010 Nov; 7(6):398-408. PubMed ID: 21103076
[TBL] [Abstract][Full Text] [Related]
9. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
10. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
Das S; Ng WK; Kanaujia P; Kim S; Tan RB
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
[TBL] [Abstract][Full Text] [Related]
11. Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats.
Ansari MJ; Anwer MK; Jamil S; Al-Shdefat R; Ali BE; Ahmad MM; Ansari MN
Drug Deliv; 2016 Jul; 23(6):1972-9. PubMed ID: 26017100
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical characterization of solid lipid nanoparticles (SLNs) prepared by a novel microemulsion technique.
Shah RM; Malherbe F; Eldridge D; Palombo EA; Harding IH
J Colloid Interface Sci; 2014 Aug; 428():286-94. PubMed ID: 24910064
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles.
Omwoyo WN; Ogutu B; Oloo F; Swai H; Kalombo L; Melariri P; Mahanga GM; Gathirwa JW
Int J Nanomedicine; 2014; 9():3865-74. PubMed ID: 25143734
[TBL] [Abstract][Full Text] [Related]
14. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
[TBL] [Abstract][Full Text] [Related]
15. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid.
Lim SJ; Kim CK
Int J Pharm; 2002 Aug; 243(1-2):135-46. PubMed ID: 12176302
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of catalase-loaded solid lipid nanoparticles protecting enzyme against proteolysis.
Qi C; Chen Y; Jing QZ; Wang XG
Int J Mol Sci; 2011; 12(7):4282-93. PubMed ID: 21845078
[TBL] [Abstract][Full Text] [Related]
17. Formulation, characterization, and in vitro/vivo studies of aclacinomycin A-loaded solid lipid nanoparticles.
Jia Y; Ji J; Wang F; Shi L; Yu J; Wang D
Drug Deliv; 2016 May; 23(4):1317-25. PubMed ID: 25371296
[TBL] [Abstract][Full Text] [Related]
18. A novel method to produce solid lipid nanoparticles using n-butanol as an additional co-surfactant according to the o/w microemulsion quenching technique.
Mojahedian MM; Daneshamouz S; Samani SM; Zargaran A
Chem Phys Lipids; 2013 Sep; 174():32-8. PubMed ID: 23743405
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Oral Absorption of All-trans Retinoic Acid upon Encapsulation in Solid Lipid Nanoparticles.
Kumar M; Sharma G; Singla D; Singh S; Kakkar V; Gulati JS; Kaur IP
Pharm Nanotechnol; 2020; 8(6):495-510. PubMed ID: 33115399
[TBL] [Abstract][Full Text] [Related]
20. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
Eskandani M; Nazemiyeh H
Eur J Pharm Sci; 2014 Aug; 59():49-57. PubMed ID: 24768857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
